Svenska                Glossary                Search    
 
 
AboutTechnologyProjectInvestorMedia Releases 2012Contact
 
 
 
 

Posters

   
   
 Society for Neuroscience 40th Annual Meeting 

 

From mice to men: a randomized, double-blind, placebo-controlled, safety-tolerability study of intracerebroventricular administration of sNN0031 (PDGF-BB) to patients with idiopathic Parkinson´s Disease using a SynchroMed® II pump: ON-GOING CLINICAL TRIAL

Society for Neuroscience 40th Annual Meeting, Nov. 13-17, 2010, San Diego, CA, USA

 

   
 World Parkinson´s Congress poster 2010 thumb  Randomized, double-blind, placebo-controlled, safety-tolerability study of intracerebroventricular administration of sNN0031 (PDGF-BB) to patients with idiopathic Parkinson´s Disease using a SynchroMed® II pump: ON-GOING CLINICAL TRIAL

World Parkinson´s Congress, Sept 28- Oct 1 , 2010, Glasgow, Scotland.
   
 Neuroscience poster 2009 thumb  Exendin-4 stimulates hippocampal neurogenesis and exerts affective and cognition associated effects in behavioral models

Society for Neuroscience 39th Annual Meeting October 17-21, 2009, Chicago, IL, USA
   
 Neuroscience poster 2008 thumb 

 

Neurorestorative effects of PDGF-BB in primate models of Parkinson's disease through stimulation of cell proliferation


Society for Neuroscience 38th Annual Meeting, Nov. 15-19, 2008, Washington, DC, USA

   
 MDS poster 2008 thumb 

 

Neurorestorative effects of PDGF-BB in models of Parkinson's disease through stimulation of cell proliferation


MDS International Congress, June 22-26, 2008,  Chicago, IL, USA

 

 
 Neurorestorative effects of PDGF-BB in rodent models of Parkinson’s disease through stimulation of cell proliferation

Society for Neuroscience 37th Annual Meeting November 3-7, 2007, San Diego, CA, USA
 
  Pharmacological Activation of Adult Neural Stem Cells by Exendin-4 as a Potential Treatment for Parkinson s Disease

Society for Neuroscience 36th Annual Meeting
October 14-18, 2006, Atlanta, GA, USA
 
  Pharmacological Activation of Endogenous Stem Cells by sNN0031 as a Therapeutic Strategy in Parkinson’s Disease.

Society for Neuroscience 35th Annual Meeting November 12-16, 2005, Washington, DC, USA
 
  In vitro characterisation of drug candidates for Therapeutic Neurogenesis

Summer school: Stem Cells & Regenerative Medicine September 16-22, 2005, Hydra, Greece
 
  The neurogenesis qualifier discovery platform for therapeutic neurogenesis

Society for Biomolecular Sciences 11th Annual Conference and Exhibition September 11-15, 2005, Geneva, Switzerland
 
  Profiling for biomarkers expressed by adult mouse neuronal stem cells (amNSC)

Ciphergen Users Conference May 9-11, 2005, Berlin, Germany
 

 

   
© NeuroNova AB, Sweden, Tel: +46 (0)8 786 0900, Email: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it  
Sitemap Site policy